Cargando…
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
Despite significant improvement in therapy and management, heart failure remains a worrisome disease state that is especially problematic in special populations. African Americans suffer a disproportionately higher prevalence of heart failure when compared to other populations. It has been recently...
Autores principales: | Echols, Melvin R, Yancy, Clyde W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994006/ https://www.ncbi.nlm.nih.gov/pubmed/17323596 |
Ejemplares similares
-
Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and
Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection
Fraction
por: Golwala, Harsh B., et al.
Publicado: (2013) -
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross‐European survey
por: Brewster, Lizzy M.
Publicado: (2019) -
Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis
por: Mavrakanas, Thomas A., et al.
Publicado: (2022) -
Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure
por: Ofili, Elizabeth, et al.
Publicado: (2017) -
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction
por: Zamani, Payman, et al.
Publicado: (2017)